Targeting KSHV/HHV-8 Latency with COX-2 Selective Inhibitor Nimesulide: A Potential Chemotherapeutic Modality for Primary Effusion Lymphoma

Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas

(2010) A. P. Bhatt et al.   BLOOD

Piracy of Prostaglandin E2/EP Receptor–Mediated Signaling by Kaposi's Sarcoma-Associated Herpes Virus (HHV-8) for Latency Gene Expression: Strategy of a Successful Pathogen

(2010) Arun George Paul et al.   CANCER RESEARCH

Distinct p53, p53:LANA, and LANA Complexes in Kaposi's Sarcoma-Associated Herpesvirus Lymphomas

(2010) W. Chen et al.   JOURNAL OF VIROLOGY

Kaposi's Sarcoma Associated Herpes Virus (KSHV) Induced COX-2: A Key Factor in Latency, Inflammation, Angiogenesis, Cell Survival and Invasion

(2010) Neelam Sharma-Walia et al.   PLoS Pathogens

The Yin and Yang of vitamin D receptor (VDR) signaling in neoplastic progression: Operational networks and tissue-specific growth control

(2009) F.C. Campbell et al.   BIOCHEMICAL PHARMACOLOGY

Lead optimization of COX-2 inhibitor nimesulide analogs to overcome aromatase inhibitor resistance in breast cancer cells

(2009) Bin Su et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

NS-398 Induces Apoptosis in Human Esophageal Cancer Cells Through Inhibition of NF-kappaB Downstream Regulation of Cyclooxygenase-2

(2009) Jun Feng Liu et al.   CANCER INVESTIGATION

Kaposi sarcoma-associated herpesvirus (KSHV): Molecular biology and oncogenesis

(2009) Kwun Wah Wen et al.   CANCER LETTERS

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

(2009) Jack Cuzick et al.   LANCET ONCOLOGY

HIV-associated lymphomas and gamma-herpesviruses

(2008) A. Carbone et al.   BLOOD

Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise

(2008) M. Bernard et al.   CURRENT PHARMACEUTICAL DESIGN

Aquaporins—new players in cancer biology

(2008) A. S. Verkman et al.   JOURNAL OF MOLECULAR MEDICINE-JMM